Organon & Co



Ebitda Veränderung Datum
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Celltrion KRW 284.19B 78.15B 2024-09
Cspc Pharmaceutical CNY 2.21B 275.77M 2023-12
Dianthus Therapeutics USD -31838000 1.96M 2024-12
Ecofibre AUD -3020000 428K 2024-06
Gilead Sciences USD 3.21B 651M 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Kangmei Pharma -3262057.35 15.91M 2024-09
Knight Therapeutics CAD 16.72M 1.05M 2024-09
Laboratorios Farma EUR 137.9M 93.62M 2024-12
Malin Corporation EUR -1300000 900K 2024-06
Medical Developments International AUD -2000000 9.47M 2024-06
Merck USD 7.12B 1.06B 2024-12
Neuren Pharmaceuticals AUD 176.7M 166.79M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Organigram Holdings CAD -16179000 63.98M 2024-12
Organon & Co USD 341M 118M 2024-12
Pharma Mar EUR 6.96M 87K 2024-12
Qiagen NV USD 177.93M 337.07M 2024-09
Sartorius EUR 181.2M 42.4M 2024-09
Sino Biopharmaceutical CNY 3.2B 955.21M 2024-12
Tilray USD -101000 2.32M 2024-11



Organon & Co - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.